Siftome Phase 2P

Ranked GEO Datasets

Active GEO index contains 25529 ranked datasets; organism mixed: Homo sapiens (13542), Mus musculus (11987); assay type mixed: bulk RNA-seq (15127), microarray (9039), other assay type (1363). Rankings use the Patient tissue tumor-vs-normal intent with transparent suitability, metadata quality, and warning rules.

Gene snapshot Projects Saved searches CSV Markdown
2 shown of 152 matching datasets Scoring intent-aware-scoring-v15 Batch 9c08145d0461e1fec7a4077ea17c91ea89b2eb7a2e58866d66ed05bdfdb1d938 Intent Patient tissue tumor-vs-normal Organism Homo sapiens Assay bulk RNA-seq Intent defaults Active 5 active filters Page 4 of 4 · showing 151-152
Active intent defaults Tumor-normal onlyTissue or biopsy onlyHide biofluid/model systemsHuman onlyBulk RNA-seq only
Study designs tumor vs matched normal or tumor vs unmatched normal
Recommendation Recommended means a human bulk RNA-seq tissue or biopsy cohort with clear tumor-normal grouping and sufficient metadata for first-pass triage.
Search intent
Intent defaults Relax defaults

Showing one page of matching results. Use next/previous for browsing, or CSV/Markdown export for the full matching set.

151
GSE32424

Identification of a Novel Angiogenesis and Tumor Suppressor Gene Rab25 in Esophageal Squamous Cell Carcinoma

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 2 warnings require review.
GEO Homo sapiens bulk RNA-seq 12 samples intent-aware-scoring-v15
GEO source Trusted counts
warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
152
GSE97239

High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 3 warnings require review.
GEO Homo sapiens bulk RNA-seq 6 samples intent-aware-scoring-v15
GEO source Trusted counts
warning Secondary RNA assay context such as small RNA, miRNA, circRNA, or non-coding RNA was detected. warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.